Results 131 to 140 of about 6,860 (236)

Nationwide genomic surveillance of carbapenem- and colistin-resistant Klebsiella pneumoniae bloodstream isolates in Thailand (2020-2024). [PDF]

Sci Rep
Krobanan K, Kamjumphol W, Leethongdee P, Unahalekhaka A, Sripichai O, Cheunban N, Thadtapong N, Kurehong C, Okada PA, Premsuriya J.   +9 more
europepmc   +1 more source

Repurposing Fingolimod as an Antibacterial and Antibiofilm Agent against Carbapenem-Resistant <i>Acinetobacter baumannii</i>. [PDF]

ACS Omega
Jin HW, Bae JH, Youn HS, Eom YB.
europepmc   +1 more source

Acid-dependent beta-lactam resistance in <i>Klebsiella pneumoniae</i> is mediated by paralogous class B PBPs and the class A PBP, PBP1b. [PDF]

mBio
Beagle S, Levin PA.
europepmc   +1 more source

Comparative phenotypic and genotypic analysis of distinct <i>Pseudomonas aeruginosa</i> T3SS effector genotypes. [PDF]

Front Cell Infect Microbiol
Alharbi NK, El-Sawy NA, Dahran NA, Atwah B, Al-Kushi AG, Alharbi M, Abdelkhalig SM, Mosbah RA, Mansour AT, Bendary MM.   +9 more
europepmc   +1 more source

Quinolone Resistance and Virulence Genes Prevalence of Uropathogenic <i>Escherichia coli</i> Isolated from Kidney Transplant Recipients with Urinary Tract Infections in Tehran, Iran. [PDF]

Res Rep Urol
Talebi G, Sadredinamin M, Hakemi-Vala M, Najafikhah A, Alizadeh A.   +4 more
europepmc   +1 more source

Detection of <i>K. pneumoniae</i> Hospital-Acquired Strains That Produce Carbapenemases in Thrace Tertiary Hospital. [PDF]

Microorganisms
Vezyridou A, Skeva A, Alexandropoulou I, Iliadi V, Euthymiou G, Themelidis D, Xanthopoulou A, Petrakis V, Konstantinidis T, Panopoulou M.   +9 more
europepmc   +1 more source

Trends in carbapenem antibiotics utilization, costs, and market dynamics in Medicaid: a retrospective analysis from 1991 to 2023. [PDF]

Front Med (Lausanne)
Alrasheed MA, Alsuhibani AA.
europepmc   +1 more source

Combinations comprising dual β-lactams and a β-lactamase inhibitor achieve optimal synergistic inhibition of <i>Mycobacterium abscessus</i> growth. [PDF]

Antimicrob Agents Chemother
Rimal B, Xie Y, Panthi CM, Devlin KL, Beatty KE, Lamichhane G.   +5 more
europepmc   +1 more source

Worldwide threatening prevalence of carbapenem-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

Epidemiol Infect
Ahmadi MH, Fagheei Aghmiyuni Z, Bakhti S.   +2 more
europepmc   +1 more source

A patient-centric paradigm and tool for clinical research: the DOOR is open. [PDF]

Antimicrob Agents Chemother
Hamasaki T, He Y, Wu Q, Howard-Anderson J, Boucher HW, Doernberg SB, Holland TL, Powers JH, Wang J, Diao G, van Duin D, Fowler VG, Chambers HF, Evans SR.   +13 more
europepmc   +1 more source